Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,706.00
(
0.27%
)
News Focus
News Focus
Post# of 257265
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 137468

Tuesday, 02/21/2012 6:49:05 PM

Tuesday, February 21, 2012 6:49:05 PM

Post# of 257265

Enanta’s NS5A inhibitor (EDP-239) was announced 2 years ago (#msg-47301187), and there was nary a peep about it until now. NVS’ back-ended deal looks much more reasonable than what other HCV suitors have been doing lately.

Enanta is also the developer of ABT’s ABT-450 PI (#msg-61757048).

Kind of interesting that NVS passed over both the IDIX and ACHN NS5As (the ACHN one being more advanced, no less) for Enanta's version.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today